Isabel R Hsu
Overview
Explore the profile of Isabel R Hsu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
491
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kabir M, Iyer M, Richey J, Woolcott O, Asare Bediako I, Wu Q, et al.
Am J Physiol Endocrinol Metab
. 2015 Aug;
309(8):E747-58.
PMID: 26306598
The improvement of hepatic insulin sensitivity by the cannabinoid receptor 1 (CB1R) antagonist rimonabant (RIM) has been recently been reported to be due to upregulation of adiponectin. Several studies demonstrated...
2.
Woolcott O, Richey J, Kabir M, Chow R, Iyer M, Kirkman E, et al.
PLoS One
. 2015 Jun;
10(6):e0131033.
PMID: 26075612
No abstract available.
3.
Woolcott O, Richey J, Kabir M, Chow R, Iyer M, Kirkman E, et al.
PLoS One
. 2015 Apr;
10(4):e0123558.
PMID: 25855974
Background: Obesity has been associated with elevated plasma anandamide levels. In addition, anandamide has been shown to stimulate insulin secretion in vitro, suggesting that anandamide might be linked to hyperinsulinemia....
4.
Ader M, Stefanovski D, Kim S, Richey J, Ionut V, Catalano K, et al.
Obesity (Silver Spring)
. 2013 Oct;
22(5):1238-45.
PMID: 24123967
Objective: Insulin resistance is a powerful risk factor for Type 2 diabetes and a constellation of chronic diseases, and is most commonly associated with obesity. We examined if factors other...
5.
Kim S, Woolcott O, Hsu I, Stefanoski D, Harrison L, Zheng D, et al.
Am J Physiol Endocrinol Metab
. 2012 Mar;
302(10):E1261-8.
PMID: 22374758
The endocannabinoid system is highly implicated in the development of insulin resistance associated with obesity. It has been shown that antagonism of the CB(1) receptor improves insulin sensitivity (S(I)). However,...
6.
Kabir M, Stefanovski D, Hsu I, Iyer M, Woolcott O, Zheng D, et al.
Obesity (Silver Spring)
. 2011 Aug;
19(11):2121-9.
PMID: 21836643
Adipocyte size plays a key role in the development of insulin resistance. We examined longitudinal changes in adipocyte size and distribution in visceral (VIS) and subcutaneous (SQ) fat during obesity-induced...
7.
Woolcott O, Bergman R, Richey J, Kirkman E, Harrison L, Ionut V, et al.
Pancreas
. 2011 Jul;
41(1):31-8.
PMID: 21792087
Objectives: The canine model has been used extensively to improve the human pancreatic islet isolation technique. At the functional level, dog islets show high similarity to human islets and thus...
8.
Hsu I, Zuniga E, Bergman R
Am J Physiol Endocrinol Metab
. 2010 Apr;
299(1):E131-6.
PMID: 20424137
Recent studies in animal and human models have revealed that free fatty acid (FFA) release from adipose tissue is oscillatory. We have shown in our laboratory that these oscillations are...
9.
Richey J, Woolcott O, Stefanovski D, Harrison L, Zheng D, Lottati M, et al.
Am J Physiol Endocrinol Metab
. 2009 Apr;
296(6):E1311-8.
PMID: 19366874
We investigated whether rimonabant, a type 1 cannabinoid receptor antagonist, reduces visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) in dogs maintained on a hypercaloric high-fat diet (HHFD). To...
10.
Hsu I, Kim S, Kabir M, Bergman R
Am J Clin Nutr
. 2008 Feb;
86(3):s867-71.
PMID: 18265480
The term metabolic syndrome describes the association between obesity, insulin resistance, and the risk of several prominent chronic diseases, including cancer. The causal link between many of these components remains...